Cargando…
Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis
Diabetic nephropathy (DN) is a common microvascular complication of diabetes and the main cause of end-stage nephropathy (ESRD). Inflammation and fibrosis play key roles in the development and progression of diabetic nephropathy. By using in vivo and in vitro DN models, our laboratory has identified...
Autores principales: | Liu, Xue-qi, Jiang, Ling, Lei, Lei, Nie, Zhen-yong, Zhu, Wei, Wang, Sheng, Zeng, Han-xu, Zhang, Shi-qi, Zhang, Qiu, Yard, Benito, Wu, Yong-gui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726623/ https://www.ncbi.nlm.nih.gov/pubmed/33241846 http://dx.doi.org/10.1042/CS20201207 |
Ejemplares similares
-
MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling
por: Shi, MingJun, et al.
Publicado: (2020) -
Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis
por: Liu, Ming Ming, et al.
Publicado: (2020) -
Effects of physical activity on the progression of diabetic nephropathy: a meta-analysis
por: Cai, Zixin, et al.
Publicado: (2021) -
Mechanisms of podocyte injury and implications for diabetic nephropathy
por: Barutta, Federica, et al.
Publicado: (2022) -
Efficacy of tripterygium glycosides combined with ARB on diabetic nephropathy: a meta-analysis
por: Wu, Xue, et al.
Publicado: (2020)